AccuSift provides high‑performance fumonisin competitive assay pairings, characterized by exceptional batch‑to‑batch consistency and optimized for IVD kit development (Lateral Flow, Chemiluminescence, ELISA, POCT). These pairings offer high affinity and specificity, facilitating rapid detection.

Fumonisins are mycotoxins produced by Fusarium verticillioides. They are water‑soluble metabolites, consisting of structurally similar diester compounds formed from different polyhydric alcohols and tricarboxylic acids.

They primarily contaminate grains and their products, cause acute toxicity in some livestock, and exhibit potential carcinogenicity, making them a major research focus after aflatoxins.

On October 27, 2017, the World Health Organization’s International Agency for Research on Cancer (IARC) listed fumonisin B1, Fusarium verticillioidesand its produced toxins (fumonisin B1, fumonisin B2, and fusarin C) as Group 2B carcinogens in its preliminary compilation.

Performance Characteristics:

Sensitivity: ELISA IC50: 2ppb; Colloidal Gold: FB1：2ppb；FB2：5ppb；FB3：5ppb

Cross‑Reactivity: FB1 100%; FB2 >80%; FB3 80

 

https://en.accusift.com/index.php?c=show&id=3432

 

Shenzhen AccuSift Biotechnology Co., Ltd. (referred to as AccuSift) was established in January 2014. It is a technology-oriented enterprise specializing in the preparation of antigens and antibodies for IVD raw materials and food safety raw materials, as well as the development and application of biotechnology. The company has an advanced and complete production platform for single and polyclonal antibodies and has prepared a variety of small molecule hapten related to IVD raw materials, pesticides and veterinary drugs, antibiotics, mycotoxins, hormones, heavy metals, pigments, etc., and high-quality monoclonal antibodies. The company provides comprehensive antibody services, antigen design, synthesis, antibody preparation and labeling, and immunological experiments for domestic and foreign users. The company's antibody research and development department has high-quality talents, strong research and development capabilities and a quality assurance system, providing high-precision and high-stability product solutions for clinical diagnosis and food safety detection.

AccuSift adheres to the business philosophy of "integrity, innovation and progress", with the mission of "focusing on the source of precision and safeguarding the beauty of health", providing strong support for researchers in the fields of clinical diagnosis and food safety.